On Monday, Atlassian Cl A got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 82.
IBD's proprietary RS Rating tracks market leadership by showing how a stock's price action over the last 52 weeks measures up against that of other stocks on the major indexes.
Decades of market research reveals that the best stocks typically have an RS Rating north of 80 as they launch their biggest climbs.
Looking For The Best Stocks To Buy And Watch? Start Here
The IBD Big Cap 20 stock is not currently near a potential buy zone. See if the stock goes on to form a promising consolidation that could ignite a new run.
The company reported 32% EPS growth last quarter. Revenue gains came in at 21%.
Atlassian Cl A earns the No. 1 rank among its peers in the Computer Software-Special Enterprise industry group. Karooooo and Atlassian Cl A are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
